Evidence map›Paper›PMID 23401703›Full record

ArticleClinical & developmental immunology2013

Monocyte signal transduction receptors in active and latent tuberculosis.

Magdalena Druszczynska, Marcin Wlodarczyk, Beata Janiszewska-Drobinska, Grzegorz Kielnierowski, Joanna Zawadzka, Magdalena Kowalewicz-Kulbat, Marek Fol, Piotr Szpakowski, Karolina Rudnicka, Magdalena Chmiela and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & developmental immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Magdalena DruszczynskaDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.
Marcin Wlodarczyk
Beata Janiszewska-Drobinska
Grzegorz Kielnierowski
Joanna Zawadzka
Magdalena Kowalewicz-Kulbat
Marek Fol
Piotr Szpakowski
Karolina Rudnicka
Magdalena Chmiela
Wieslawa Rudnicka
University of Łódź · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms that promote either resistance or susceptibility to TB disease remain insufficiently understood. Our aim was to compare the expression of cell signaling transduction receptors, CD14, TLR2, CD206, and β2 integrin LFA-1 on monocytes from patients with active TB or nonmycobacterial lung disease and healthy individuals with M.tb latency and uninfected controls to explain the background of the differences between clinical and subclinical forms of M.tb infection. A simultaneous increase in the expression of the membrane bound mCD14 receptor and LFA-1 integrin in patients with active TB may be considered a prodrome of breaking immune control by M.tb bacilli in subjects with the latent TB and absence of clinical symptoms.

Indexed as

AdultAgedBiomarkersCD18 AntigensDisease ProgressionDisease SusceptibilityFemaleHumansLatent TuberculosisLectins, C-TypeLymphocyte Function-Associated Antigen-1MaleMannose-Binding LectinsMannose ReceptorMiddle AgedMonocytesBiomarkersCD18 AntigensLectins, C-TypeLymphocyte Function-Associated Antigen-1Mannose-Binding LectinsMannose ReceptorReceptors, Cell SurfaceReceptors, IgGToll-Like Receptor 2

Identifiers

PMID23401703
PMCPMC3562648
OpenAlexW2159823232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.